{
    "summary": "Bafna Pharmaceuticals Limited is a pharmaceutical company that has experienced a decline in growth due to financial constraints, resulting in a net loss of Rs. 19.08 Cr in 2017. Despite this, the company remains optimistic about its future prospects, citing its strong manufacturing facilities, R&D wing, and expanding customer base. The company plans to invest in building its necessary systems and infrastructure to manage its growth and is evaluating options to raise additional funds.",
    "bankruptcy_level": {
        "lvl": "0.6"
    },
    "entities": [
        {
            "entity": "Bafna Pharmaceuticals Limited",
            "type": "COMPANY"
        },
        {
            "entity": "Pharmaceutical industry",
            "type": "EVENT"
        },
        {
            "entity": "GST",
            "type": "EVENT"
        },
        {
            "entity": "R&D",
            "type": "PRODUCT"
        }
    ],
    "relations": [
        {
            "source": "Bafna Pharmaceuticals Limited",
            "target": "Pharmaceutical industry",
            "relation": "PARTICIPATES_IN",
            "properties": {
                "Role": "Participant",
                "Effect": "0.5"
            }
        },
        {
            "source": "Bafna Pharmaceuticals Limited",
            "target": "GST",
            "relation": "PARTICIPATES_IN",
            "properties": {
                "Role": "Participant",
                "Effect": "0.4"
            }
        },
        {
            "source": "Bafna Pharmaceuticals Limited",
            "target": "R&D",
            "relation": "PRODUCES",
            "properties": {
                "Production Volume": "1000",
                "Production Start Date": "2015-01-01"
            }
        },
        {
            "source": "GST",
            "target": "Bafna Pharmaceuticals Limited",
            "relation": "HAD_NEGATIVE_IMPACT_ON",
            "properties": {
                "Impact Level": "0.6",
                "Impact Type": "Financial",
                "Reason": "Increased taxation"
            }
        },
        {
            "source": "Pharmaceutical industry",
            "target": "Bafna Pharmaceuticals Limited",
            "relation": "HAD_POSITIVE_IMPACT_ON",
            "properties": {
                "Impact Level": "0.4",
                "Impact Type": "Reputation",
                "Reason": "Increased demand for pharmaceuticals"
            }
        }
    ]
}